Bio-Rad Laboratories (BIO-B) Net Income towards Common Stockholders Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 98.96% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.60% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.10% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Bio-Rad Laboratories | - | - | 309.40 Mn | -923.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -923.59% |
| Dec 31, 2025 | 200.59% |
| Sep 30, 2025 | -152.34% |
| Jun 30, 2025 | 114.68% |
| Mar 31, 2025 | -83.33% |
| Dec 31, 2024 | -304.67% |
| Sep 30, 2024 | 514.75% |
| Jun 30, 2024 | -86.32% |
| Mar 31, 2024 | 456.68% |
| Dec 31, 2023 | -57.75% |
| Sep 30, 2023 | 165.26% |
| Jun 30, 2023 | -25.63% |
| Mar 31, 2023 | 102.05% |
| Dec 31, 2022 | 152.89% |
| Sep 30, 2022 | -104.14% |
| Jun 30, 2022 | -201.20% |
| Mar 31, 2022 | -444.51% |
| Dec 31, 2021 | -284.80% |
| Sep 30, 2021 | 198.75% |
| Jun 30, 2021 | -5.41% |
| Mar 31, 2021 | 42.50% |
| Dec 31, 2020 | 53.05% |
| Sep 30, 2020 | 608.01% |
| Jun 30, 2020 | 61.39% |
| Mar 31, 2020 | -20.72% |
| Dec 31, 2019 | 166.80% |
| Sep 30, 2019 | -196.11% |
| Jun 30, 2019 | 123.40% |
| Mar 31, 2019 | 31.73% |
| Dec 31, 2018 | -1,101.80% |
| Sep 30, 2018 | 1,120.35% |
| Jun 30, 2018 | 5,223.59% |
| Mar 31, 2018 | 5,211.22% |
| Dec 31, 2017 | 543.67% |
| Sep 30, 2017 | 29.05% |
| Jun 30, 2017 | -69.67% |
| Mar 31, 2017 | 12.42% |
| Dec 31, 2016 | -140.84% |
| Sep 30, 2016 | -1.55% |
| Jun 30, 2016 | -41.60% |
| Mar 31, 2016 | -38.26% |
| Dec 31, 2015 | 16.87% |
| Sep 30, 2015 | 50.93% |
| Jun 30, 2015 | -10.14% |
| Mar 31, 2015 | 167.22% |
| Dec 31, 2014 | 29.58% |
| Sep 30, 2014 | 262.12% |
| Jun 30, 2014 | -8.59% |
| Mar 31, 2014 | -66.94% |
| Dec 31, 2013 | -29.32% |
| Sep 30, 2013 | -116.89% |
| Jun 30, 2013 | -27.85% |
| Mar 31, 2013 | -33.96% |
| Dec 31, 2012 | -28.39% |
| Sep 30, 2012 | -7.37% |
| Jun 30, 2012 | 20.08% |
| Mar 31, 2012 | -3.76% |
| Dec 31, 2011 | -7.12% |
| Sep 30, 2011 | 11.23% |
| Jun 30, 2011 | 90.92% |
| Mar 31, 2011 | -10.31% |
| Dec 31, 2010 | 236.82% |
| Sep 30, 2010 | 3.78% |
| Jun 30, 2010 | -64.69% |